T cell receptor alpha variable 1-1 (TRAV1-1)

T cell receptor alpha variable 1-1 (TRAV1-1) is a gene encoding one of the variable (V) segments of the T cell receptor (TCR) alpha chain, an essential component of the adaptive immune system's machinery for recognizing peptide antigens presented on major histocompatibility complex (MHC) molecules at the surface of antigen presenting cells[1][2]. TRAV1-1 encodes the variable domain of the alpha chain and contributes, in conjunction with a paired beta chain, to the highly diverse antigen-binding site of the TCR heterodimer[1][2][3][4]. TRAV1-1, along with other V, J, and C gene segments, undergoes somatic recombination in developing T cells in the thymus (VJ recombination) to generate the immense diversity required for antigen specificity[1][2]. While the TCR as a whole is an established therapeutic target in immunotherapy (e.g., checkpoint inhibitors, CAR-T therapies), there are no known clinically used drugs targeting the TRAV1-1 segment specifically. The function of TRAV1-1 is critical for antigen recognition, immune activation, and downstream signaling through associated CD3 signaling chains and ITAM motifs[1][2][4]. Abnormalities in TCR usage, including skewing or clonality of variable segments like TRAV1-1, can be detected in certain diseases such as infections, cancers, and autoimmune disorders and may serve as a research or diagnostic biomarker[1][2][4].

Other names

TRAV1-1TRAV11TCRAV1S1TCRAV7S1TVA11

Not applicable (TRAV1-1 itself is not directly targeted by drugs; T cell receptor modulators would affect the TCR as a whole, often via broader immunomodulation)